Silco Pharmaceuticals Limited

SILCOPHL

BD0495SILCO6

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
19.2 ^BDT	+1.59%		-4.48%	-17.95%

May. 01	Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Feb. 07	Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021

November 24, 2021 at 10:04 am EST

The Board of Directors of Silco Pharmaceuticals Limited has recommended 10% cash dividend for all shareholders excluding Directors for the year ended on June 30, 2021.

Latest news about Silco Pharmaceuticals Limited

Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 30	CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 06	CI
Silco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 29	CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for All Shareholders Excluding Directors for the Year Ended June 30, 2023	Nov. 27	CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Silco Pharmaceuticals Limited Approves Cash Dividend for the Year Ended June 30, 2022	23-01-10	CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022	22-11-06	CI
37,316,700 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2022.	22-02-10	CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021	21-11-24	CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020	20-11-02	CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Year Ended on June 30, 2020	20-11-02	CI
Silco Pharmaceuticals Limited Signs First Export Agreement with Zaid Elyas Adil Ltd	20-08-22	CI
27,053,300 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2020.	20-02-10	CI
Silco Pharmaceuticals Limited Recommends Dividend for the Year Ended June 30, 2019	19-10-27	CI
Silco Pharmaceuticals Limited Announces Earnings Results for the Third Quarter and Nine Months Ended Period Ended on 31 March 2019	19-06-12	CI
Silco Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.	19-04-10	CI
Silco Pharmaceuticals Limited has filed an IPO in the amount of BDT 300 million.	18-08-19	CI

Chart Silco Pharmaceuticals Limited

Duration

Period

More charts

Silco Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of antibiotics, analgesics, anti-diabetics, narcotics, antipyratics, anti-inflammatory drugs, antiulcerants and multi medicines. The Companyâs biological products include Viton Syrup, Polylac Syrup, Sliflox Tablet, Vitom-B Tablet, Peristal Tablet, Bactacef Capsule, Bactazim Capsule and others. The Company manufactures products in various dosage forms including tablet, capsule, liquid syrup, dry syrup, pellet, powder and powder suspension.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SILCO PHARMACEUTICALS LIMITED	-17.95%	16.98M
ELI LILLY AND COMPANY	+37.78%	723B
NOVO NORDISK A/S	+31.16%	598B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	331B
ABBVIE INC.	+5.14%	288B
ASTRAZENECA PLC	+16.26%	244B
ROCHE HOLDING AG	-4.95%	208B
NOVARTIS AG	+10.05%	210B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals